Cargando…

Clinical Impact of Prognostic Nutrition Index for Advanced Gastric Cancer Patients with Peritoneal Metastases Treated Nivolumab Monotherapy

Although nivolumab shows survival benefits for patients with advanced gastric cancer (AGC), predictive biomarkers for nivolumab treatment in AGC remain unclear, especially in the case of peritoneal metastases. This study investigated the clinical significance of the prognostic nutrition index (PNI),...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Jungmin, Choi, Soo Ho, Baek, Jin Ho, Baek, Dong Won, Kim, Jong Gwang, Kang, Byung Woog
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Chonnam National University Medical School 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8813651/ https://www.ncbi.nlm.nih.gov/pubmed/35169556 http://dx.doi.org/10.4068/cmj.2022.58.1.24

Ejemplares similares

The Predictive Value of Epstein-Barr Virus-Positivity in Patients Undergoing Gastrectomy Followed by Adjuvant Chemotherapy
por: Baek, Dong Won, et al.
Publicado: (2018)

Clinical Significance of p53 Protein Expression, Beta-catenin Expression and HER2 Expression for Epstein-Barr Virus-associated Gastric Cancer
por: Baek, Dong Won, et al.
Publicado: (2017)

Prognostic nutritional index is an independent prognostic factor for gastric cancer patients with peritoneal dissemination
por: Nie, Runcong, et al.
Publicado: (2016)

Taxanes in the Treatment of Advanced Gastric Cancer
por: Kang, Byung Woog, et al.
Publicado: (2016)

Diffuse alveolar hemorrhage with nivolumab monotherapy
por: Shannon, Vickie R., et al.
Publicado: (2020)

Healthcare cost comparison analysis of nivolumab in combination with ipilimumab versus nivolumab monotherapy and ipilimumab monotherapy in advanced melanoma
por: Potluri, Ravi, et al.
Publicado: (2019)

Onodera's Prognostic Nutritional Index as a Risk Factor for Mortality in Peritoneal Dialysis Patients
por: Kang, Seok Hui, et al.
Publicado: (2012)

Hepatic Resection for Hepatic Metastases from Gastric Adenocarcinoma
por: Baek, Hyoung-Un, et al.
Publicado: (2013)

Clinical implication of adjuvant chemotherapy according to mismatch repair status in patients with intermediate-risk stage II colon cancer: a retrospective study
por: Kang, Byung Woog, et al.
Publicado: (2021)

The potential clinical utility of cell-free DNA for gastric cancer patients treated with nivolumab monotherapy
por: Inagaki, Chiaki, et al.
Publicado: (2023)

Clinical significance of tumor-infiltrating lymphocytes for gastric cancer in the era of immunology
por: Kang, Byung Woog, et al.
Publicado: (2017)

Prognostic factors to predict the survival in patients with advanced gastric cancer who receive later‐line nivolumab monotherapy—The Asahikawa Gastric Cancer Cohort Study (AGCC)
por: Tanaka, Kazuyuki, et al.
Publicado: (2021)

Severe complications of nivolumab monotherapy in an adolescent with malignant melanoma
por: Grzegorczyk, Aleksandra, et al.
Publicado: (2023)

Clinical significance of computed tomography-detected ascites in gastric cancer patients with peritoneal metastases
por: Kim, Su Hwan, et al.
Publicado: (2018)

A Case of Advanced Gastric Cancer with Peritoneal Metastasis Treated Successfully with Nivolumab
por: Tazawa, Hirofumi, et al.
Publicado: (2019)

Successful Conversion Surgery for Stage IV Gastric Cancer after Nivolumab Monotherapy as Third-Line Chemotherapy
por: Watanabe, Hayato, et al.
Publicado: (2021)

Proteogenomic landscape of gastric adenocarcinoma peritoneal metastases
por: Zhao, Shuangtao, et al.
Publicado: (2023)

Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 study
por: Kang, Yoon-Koo, et al.
Publicado: (2021)

The delta neutrophil index is a prognostic factor for postoperative mortality in patients with sepsis caused by peritonitis
por: Kim, Jong Wan, et al.
Publicado: (2017)

Treatment Patterns and Changes in Quality of Life during First-Line Palliative Chemotherapy in Korean Patients with Advanced Gastric Cancer
por: Kim, Jin Won, et al.
Publicado: (2019)

Treatment of patients with peritoneal metastases from gastric cancer
por: Kitayama, Joji, et al.
Publicado: (2018)

Prevention and Treatment of Peritoneal Metastases from Gastric Cancer
por: Sugarbaker, Paul H.
Publicado: (2021)

Review of Regional Therapies for Gastric Cancer with Peritoneal Metastases
por: Sun, Beatrice J., et al.
Publicado: (2022)

Third-Line Nivolumab Monotherapy in Recurrent SCLC: CheckMate 032
por: Ready, Neal, et al.
Publicado: (2018)

A multicenter, open-label, single-arm phase I trial of neoadjuvant nivolumab monotherapy for resectable gastric cancer
por: Hasegawa, Hirotaka, et al.
Publicado: (2022)

Confirmed complete response to nivolumab for advanced gastric cancer with peritoneal dissemination: a case report
por: Takami, Tomoya, et al.
Publicado: (2021)

Clinical Significance of MET Gene Copy Number in Patients with Curatively Resected Gastric Cancer
por: Kang, Byung Woog, et al.
Publicado: (2015)

The relationship between the prognostic nutritional index and new-onset pneumonia in peritoneal dialysis patients
por: Shang, Sijia, et al.
Publicado: (2022)

Clinical significance of insulin-like growth factor gene polymorphisms with survival in patients with gastrointestinal stromal tumors
por: Kwon, Ohkyoung, et al.
Publicado: (2012)

Prognostic value of prognostic nutritional index and its variations in advanced non‐small‐cell lung cancer patients treated with anlotinib monotherapy
por: Chen, Tian, et al.
Publicado: (2022)

Prognostic factors in hepatocellular carcinoma patients with bone metastases
por: Kim, Sungmin, et al.
Publicado: (2019)

Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2): 3-year update and outcome of treatment beyond progression with nivolumab
por: Boku, Narikazu, et al.
Publicado: (2021)

Marked improvement of oral intake with nivolumab monotherapy in a patient with microsatellite instability‐high gastric cancer with insufficient oral intake
por: Ogata, Takatsugu, et al.
Publicado: (2020)

Intratumoural PD-L1 expression is associated with worse survival of patients with Epstein–Barr virus-associated gastric cancer
por: Seo, An Na, et al.
Publicado: (2017)

A Study of Safety and Efficacy of Nivolumab and Bendamustine (NB) in Patients With Relapsed/Refractory Hodgkin Lymphoma After Nivolumab Monotherapy Failure
por: Lepik, Kirill V., et al.
Publicado: (2020)

Efficacy and safety of nivolumab combined with brentuximab vedotin after nivolumab monotherapy failure in patients with relapsed and refractory classic Hodgkin lymphoma
por: Fedorova, Liudmila V., et al.
Publicado: (2021)

Omental Tissue-Mediated Tumorigenesis of Gastric Cancer Peritoneal Metastases
por: Kersy, Olga, et al.
Publicado: (2019)

Gastric cancer with peritoneal metastases: Efficiency of standard treatment methods
por: Yarema, Roman, et al.
Publicado: (2020)

Gastric Cancer with Peritoneal Metastases: Current Status and Prospects for Treatment
por: Manzanedo, Israel, et al.
Publicado: (2023)

Prognostic Relevance of the Peritoneal Surface Disease Severity Score Compared to the Peritoneal Cancer Index for Colorectal Peritoneal Carcinomatosis
por: Ng, Jia Lin, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_aqsarq2dutve0abrbv3mnitj8h